GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Aflac Inc (WBO:AFL) » Definitions » Change In Payables And Accrued Expense

Aflac (WBO:AFL) Change In Payables And Accrued Expense : €-688 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aflac Change In Payables And Accrued Expense?

Aflac's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was €141 Mil. It means Aflac's Accounts Payable & Accrued Expense for Financial Companies increased by €141 Mil from Jun. 2024 to Sep. 2024 .

Aflac's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €-887 Mil. It means Aflac's Accounts Payable & Accrued Expense for Financial Companies declined by €887 Mil from Dec. 2022 to Dec. 2023 .


Aflac Change In Payables And Accrued Expense Historical Data

The historical data trend for Aflac's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aflac Change In Payables And Accrued Expense Chart

Aflac Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -219.60 -1,166.42 84.96 -480.50 -886.74

Aflac Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122.75 -621.73 267.72 -475.65 141.46

Aflac Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense for Financial Companies. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-688 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aflac Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Aflac's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Aflac Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Aflac Inc (WBO:AFL) » Definitions » Change In Payables And Accrued Expense
Address
1932 Wynnton Road, Columbus, GA, USA, 31999
Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.